Edition:
United Kingdom

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

0.37USD
19 Jan 2018
Change (% chg)

$-0.00 (-0.82%)
Prev Close
$0.37
Open
$0.36
Day's High
$0.37
Day's Low
$0.35
Volume
35,375
Avg. Vol
80,150
52-wk High
$2.64
52-wk Low
$0.31

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

16 Jan 2018

BRIEF-Tenax Therapeutics says company's board is continuing its review of strategic alternatives

* Tenax Therapeutics provides regulatory update on Levosimendan

28 Jul 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.38 +0.48
Merck & Co., Inc. (MRK.N) $61.28 +0.15
Roche Holding Ltd. (ROG.S) CHF234.50 +1.30
Roche Holding Ltd. (RO.S) CHF237.80 +1.00
Abbott Laboratories (ABT.N) $59.31 +0.24
Bayer AG (BAYGn.DE) €104.08 +0.60
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.95 +0.58
Eli Lilly and Co (LLY.N) $85.49 -0.33
Bristol-Myers Squibb Co (BMY.N) $62.28 +0.45

Earnings vs. Estimates